Kazakhstan vs Latvia: Death rate from cardiomyopathy myocarditis endocarditis who ghe age
Kazakhstan
31.11
in 2021
Latvia
37.56
in 2021
Kazakhstan rank
4th
Latvia rank
3rd
Death rate from cardiomyopathy myocarditis endocarditis who ghe age over time
- Kazakhstan
- Latvia
How they compare
Latvia currently reports 37.56 against 31.11 in Kazakhstan, a difference of 6.45.
That makes Latvia's figure about 1.2 times Kazakhstan's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Latvia ahead.
Kazakhstan ranks 4th and Latvia ranks 3rd of 194 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.32 | 30.87 | 0.4494 | Kazakhstan |
| 2010s | 42.18 | 29.16 | 13.02 | Kazakhstan |
| 2020s | 33.09 | 31.35 | 1.74 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cardiomyopathy myocarditis endocarditis who ghe age, Kazakhstan or Latvia?
- Latvia, at 37.56 against 31.11 in Kazakhstan as of 2021.
- What is the difference in death rate from cardiomyopathy myocarditis endocarditis who ghe age between Kazakhstan and Latvia?
- 6.45, with Latvia ahead.
- How many years of comparable data are there for Kazakhstan and Latvia?
- 22 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Latvia rank globally for death rate from cardiomyopathy myocarditis endocarditis who ghe age?
- Kazakhstan ranks 4th and Latvia ranks 3rd of 194 countries.
- Where does this data come from?
- Our World in Data, published as Death rate from cardiomyopathy myocarditis endocarditis who ghe age standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.